drugset / Trial / NCT02495454

GA101-miniCHOP Regimen for the Treatment of Elderly Unfit Patients With Diffuse Large B-cell Non-Hodgkin's Lymphoma

NCT02495454 ↗

Phase 2 Terminated 34 enrolled Fondazione Italiana Linfomi - ETS
NaSingle-groupOpen-labelTreatment

Summary

GA101-miniCHOP regimen for the treatment of elderly unfit patients with diffuse large B-cell non-Hodgkin's lymphoma.

Timeline

Start
2015-08-25
Primary completion
2017-03-22
Completion
2017-03-22

Outcome

Outcome not reported

Stopped: “Primary objective not obtained after interim analysis”

Drugs

EvaluationDrugModalityDoseRoute
Subject Obinutuzumab Monoclonal antibody 1000 mg Intravenous